
zzso zzso zzso zzso are an emerging class of zzso of zzso These zzso are released in zzso in patients with systemic inflammatory diseases and allergic zzso zzso may activate inflammatory cells by both zzso and zzso zzso The aim of this study was to evaluate the effect of the zzso zzso zzso on zzso zzso of primary human zzso 

zzso isolated from human lung tissue were zzso zzso zzso with zzso zzso zzso before stimulation with 2 distinct zzso zzso zzso and group zzso At the end of incubation the release of zzso zzso and zzso was assessed by zzso zzso zzso for these products was determined by quantitative zzso zzso of zzso zzso zzso 1/2 and zzso was assessed by Western zzso 

zzso inhibited the release of zzso zzso and zzso from zzso zzso in a zzso zzso The zzso effect of zzso was due to a reduction of gene expression and was complete after 18 h of zzso zzso had no effect on zzso zzso acid zzso and zzso assessed as zzso zzso zzso of zzso production by zzso was associated with zzso of zzso zzso 1/2 and zzso zzso 

zzso zzso the production of zzso zzso from human lung zzso activated by zzso zzso represents the first example of a drug able to block the zzso effects of zzso on human inflammatory cells and, therefore, may provide a useful therapeutic options for diseases associated with enhanced release of zzso in zzso 

